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Minimum inhibitory concentrations (MIC) of 13 antimicrobial agents were determined by broth microdilution for 72
Campylobacter jejuni strains from livestock. Twenty-three (31.9%) isolates were fully susceptible; all isolates were susceptible to
erythromycin, chloramphenicol, streptomycin, gentamicin, sulfamethoxazole, and meropenem, and all but one to kanamycin.
Resistance to quinolones was highest (52.8%), reaching similar values among poultry, dairy cattle, and sheep, but lower in beef
cattle. Resistance to tetracyclines (48.6%) was mainly associated to dairy cattle and β-lactams (26.4%) to poultry. Multidrug
resistance was mainly detected in dairy cattle (28.6%) and poultry (21.0%), whereas beef cattle had the highest percentage of fully
susceptible isolates. Two real-time PCR assays to detect point mutations associated to quinolone (C257T in the gyrA gene) and
macrolide(A2075Ginthe23SrRNAgenes)resistanceweredevelopedandvalidatedonthesestrains.Theanalysisofafurthersetof
88isolatesbyreal-timePCRconﬁrmedtheabsenceofmacrolideresistanceanddemonstratedthereproducibilityandprocessability
of the assay.
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1.Introduction
Campylobacters are asymptomatically present in the intesti-
nal tract of a wide range of mammals and birds, including
domestic farm animals, which constitute potential sources
for human infection via contamination of food and water.
The incidence of Campylobacter jejuni has increased during
the last decade, and today it is the leading cause of bacterial
enteritis in most developed countries [1, 2]. Although the
majority of Campylobacter infections are self-limiting, com-
plicated cases may warrant antimicrobial therapy. Antimi-
crobial susceptibility data show an increase in the number of
ﬂuoroquinolone-resistant and, to a lesser extent, macrolide-
resistant Campylobacter strains causing human infections.
Resistanceproblemsinhumanmedicinearemainlylinkedto
human misuse of antimicrobial agents, but there is accumu-
latingevidencethatantimicrobialresistanceoriginatingfrom
the use of antimicrobials in food animals might complicate
therapy of human infections [3, 4]. Antimicrobials used
therapeutically or prophylactically in animal husbandry can
also exert selective pressure on bacteria that infect food
animals and reach humans via food products [5]. Local
and international committees have highlighted the need
for better control of antibiotics usage in human medicine
and veterinary husbandry [2]. In this sense, systematic
monitoring of the occurrence of antimicrobial resistance in
C. jejuni originating from animals can serve as an indicator
of the selective pressure these bacteria are undergoing and
help in early detection of resistance development.
A prevalence study recently carried out in the Basque
Country (Northern Spain) identiﬁed 28.3% (34/120) of
ovine and 18.0% (37/206) of bovine farms positive for C.
jejuni [6], and even higher values (38.2%, 13/34) in free-
range poultry farms [7]. The high incidence of human
Campylobacter infections in the Basque Country (114 cases
per 100,000 inhabitants in 2006) and the relatively high
prevalence in primary production units of this foodborne
pathogen prompted us to determine the antimicrobial
resistance proﬁles of a selection of C. jejuni isolated from
animal faeces in the Basque Country over two years [6, 7].2 International Journal of Microbiology
2.MaterialsandMethods
2.1.SelectionofIsolates. C.jejuniisolateswereselectedfroma
prevalencestudyofthermophiliccampylobactersinlivestock
carriedoutintheBasqueCountry(NorthernSpain)between
October 2003 and May 2005 [6, 7]. To avoid bias, isolates
wereselected on the basis of isolation source(host, farm, and
ﬂock).Hence,the72isolatesanalysedbybrothmicrodilution
included 19 isolates from 12 poultry farms (18 ﬂocks), 25
from dairy sheep (21 farms), and 28 isolates from cattle
(14 beef cattle and 11 dairy cattle farms). When isolates
were related epidemiologically, that is, originating from the
same ﬂock/herd, previous ﬂaA PCR-RFLP and PFGE typing
data [6, 7] were considered to select genetically unrelated
strains. Thus, the 72 isolates could be discriminated into 50
PFGE and 28 ﬂaA PCR-RFLP types. With the exception of
isolates from beef cattle, some of the additional 88 isolates
analysed by real-time PCR were in some manner related to
theinitialsetof72isolates(isolatedfromanimalsinthesame
herd/ﬂock) and therefore not used to estimate prevalence
rates of resistance.
C. jejuni strains from the CAMPYNET collection (strain
CNET-015 susceptible to both macrolides and quinolones;
strainCNET-077resistanttoquinolones)andCampylobacter
coli strain 0402587 (resistant to macrolides) were used as
controls for SNP detection by real-time PCR.
2.2. Broth Microdilution Test. Minimum inhibitory concen-
trations (MIC) were determined for 72 strains isolated from
poultry (19), dairy sheep (25), and cattle (28) by broth
microdilution using a custom-designed Susceptibility Plate
(Sensititre, Trek Diagnostic Systems) containing serial two-
fold dilutions of 13 antimicrobial agents (Table 1). C. jejuni
inocula for MIC were prepared from overnight growth on
Columbia agar incubated in microaerobic atmosphere (10%
CO2,5 %O 2, 85% N2)a t4 1 .5 ± 1◦C by suspension in 5mL
of Sensititre Standardization Broth (turbidity equivalent
to 0.5 McFarland standard). One hundred microlitres of
the suspension were transferred into 11mL of cation-
adjusted Mueller-Hinton supplemented with 5% lysed horse
blood, and 100μL were then used to inoculate the 96-
well panel to give a ﬁnal concentration of 105 cfu/mL.
After microaerobic incubation for 24 hours at 41.5 ±
1◦C, growth in each well was compared with that of
the positive control (well with no antimicrobial drug)
and MICs recorded as the lowest concentration of the
antimicrobial that completely inhibited growth, except for
sulfamethoxazole, for which MICs were set to the lowest
concentration that inhibited 80% of growth. Results were
interpretedusingepidemiologicalcut-oﬀvaluesbasedonthe
distribution of MICs of wild type susceptible populations
as developed by the European Committee for Antimicro-
bial Susceptibility Testing (EUCAST, http://www.eucast.org),
except for kanamycin, meropenem, and sulfamethoxazole,
where CLSI breakpoints between susceptible and intermedi-
ate for Enterobacteriaceae strains were used [8] as indicated
in Table 1.
2.3. SNP Discrimination by Real-Time PCR. Two TaqMan
real-time PCR assays were developed to detect point muta-
tions associated to quinolone (C257T in the gyrAg e n e ,T h r -
86-Ile) and macrolide (A2075G mutation in the 23S rRNA
genes) resistance. Diﬀerent Minor Grove Binding (MGB) and
Locked Nucleic Acid (LNA) probes were tested, and those
combinations providing the best mismatch discrimination
(based on net ﬂuorescent diﬀerence between maximal and
minimal ﬂuorescent signals and the beginning of the expo-
nential growth phase of the reaction) were selected. Ten μL
reactions included 900nM of each primer, 100–200nM of
probe (Table 2), 1 × TaqMan Universal Master Mix (Applied
Biosystems) and Ampli-Taq Gold DNA polymerase, and 5ng
of template DNA. PCR reactions were run on an ABI Prism
7500 Sequence Detection System (Applied Biosystems) using
the following program: 10 minutes at 95◦C, and 40 cycles
o f1 5sa t9 5 ◦C, and 1 minute at 60◦C. SNP discrimination
by real-time PCR was initially performed on the 72 isolates
analysed phenotypically and then used to genotypically
characterise a further set of 88 isolates, adding up to a total
of 160 isolates distributed as follows: 36 poultry isolates from
13 farms (21 ﬂocks), 44 ovine isolates from 35 farms, and 80
cattle isolates from 38 farms.
2.4. Statistical Analyses. Comparison of frequencies of resis-
tance/susceptibility among host species was carried out
using Fisher exact test, and quantitative MIC values were
transformed into a base 2 logarithm to reduce variability
and to have a two-fold scale for the ﬁnal units, and then
submitted to analysis of variance and comparison of least
square means in a factorial design for antibiotic and host
species using the GLM procedure on the SAS statistical
p a c k a g ev e r s i o n8 . 0( S A SI n s t i t u t e ,U S A ) .P-values less
than .05 were considered signiﬁcant.
3. Results
Distribution of MICs for the 72 C. jejuni strains analysed
by broth microdilution are shown in Table 1. Twenty-three
(31.9%) isolates were susceptible to all the 13 antimicro-
bial agents. In addition, all isolates were susceptible to
erythromycin (MICs not higher than 0.5mg/L), chloram-
phenicol, streptomycin, gentamicin, sulfamethoxazole, and
meropenem, and most of them (83.3%) had MIC values of
2–4mg/L for kanamycin, with only one isolate from dairy
cattle resistant. Resistance to quinolones and tetracyclines
was the most common trait. Hence, 38 isolates (52.8%)
were resistant to both ciproﬂoxacin and nalidixic acid, while
the remaining 34 (47.2%) were susceptible to both (MIC
≤ 0.25 and 8, respectively). Resistance to tetracycline was
observed for 35 (48.6%) isolates, with MIC ≥ 16mg/L for
30 of them. All but one of the isolates resistant to tetracycline
were also resistant to doxycycline, the one exception being
an ovine isolate with an MIC value of 8 for tetracycline
and 0.5 for doxycycline. Nineteen (26.4%) isolates were
resistant to ampicillin and amoxicillin. Multidrug resistance
deﬁned as resistance to three or more classes of antimicrobial
agents, was present in 10 C. jejuni isolates (Table 3), mainlyInternational Journal of Microbiology 3
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Table 2: Primers and probes sequences.
Target Name Sequences (5  → 3 )C ( n M )
gyrA gyr-Fw GGGTGCTGTTATAGGTCGTTATCA 900
gyr-Rv TTGAGCCATTCTAACCAAAGCAT 900
Probe-gyr-S HEX – CAT[+G]GAGAT[+A][+C][+A]GC[+A]GTTT – BHQ1 150
Probe-gyr-R FAM – CATGGAGATATAGCAGTTT – MGB 150
23S 23S-Fw CAGTGAAATTGTAGTGGAGGTGAAA 900
23S-Rv TTCTTATCCAAATAGCAGTGTCAAGCT 900
Probe-23S-S HEX – CGGGGTC[+T][+T][+T]CCGTCTTG – BHQ1 100
Probe-23S-R FAM – CGGGGTC[+T][+C][+T]CCGTCTTG – BHQ1 200
LNA nucleotides are indicated by a + symbol and in brackets; SNPs are underlined
associatedtodairycattle(28.6%),closelyfollowedbypoultry
(21.0%). Another 23 isolates were resistant to two classes of
antibiotics, most of them to quinolones and tetracyclines.
It was interesting to note that the overall resistance
prevalence found for isolates from beef cattle was lower
compared to sheep, dairy cattle, and poultry. Hence, beef
cattlewerethehostspecieswiththehighestpercentageofiso-
lates sensitive to all 13 tested antimicrobial agents (50.0%),
whereassheephadthelowest(24.0%)(Table 3).Thenumber
of isolates tested phenotypically was too small to provide
any statistical resolution when comparing the frequencies
of resistance/susceptibility among host species. However,
comparison of MIC values showed a diﬀerent distribution
for isolates from diﬀerent host species (Figure 1). Analysis
of variance and comparison of log-transformed mean MIC
values detected signiﬁcantly lower values for quinolones
among C. jejuni from beef cattle compared to all other three
host species (P<. 05) which did not diﬀer among themselves
(Figure 1(a)). Similarly, values for tetracyclines and β-
lactamsalsodiﬀeredbetweenspecies(Figures1(b)and1(c)).
Since ﬂuoroquinolones and macrolides are the drugs
of choice for the treatment of Campylobacter infections,
two real-time PCR assays were developed to rapidly deter-
mine the distribution of genetic determinants associated
to resistance to these antimicrobials: point mutations in
the gyrA gene encoding the GyrA subunit of the DNA
gyrase associated to quinolone resistance (C257T in the
gyrA gene, Thr-86-Ile) and in the domain V of the 23S
rRNA gene (A2075G mutation) that mediates resistance
to macrolides. SNP discrimination by real-time PCR was
initially performed on the 72 C. jejuni strains phenotypically
analysed by broth microdilution. When compared with
phenotypic results, real-time PCR detected the gyrAg e n e
C → T nucleotide point mutationin all the strains identiﬁed
as resistant to ciproﬂoxacin and nalidixic acid by broth
microdilution, but none of the susceptible ones. Also in fully
agreement with the phenotypic antimicrobial sensitivity test,
none of the strains had the A2075G mutation in the 23S
rRNA genes that confers resistance to macrolides, as shown
by real-time PCR. Once established the 100% concordance
between broth microdilution and real-time PCR, a further
set of 88 isolates was then genotypically analysed by real-
time PCR. Again, all of them were susceptible to macrolides
but resistance to quinolones was observed. Overall, 89 of 160
isolates had the quinolone-resistant mutation in the gyrA
gene, with a similar distribution among diﬀerent host to that
observedbybrothmicrodilution.Comparisonoffrequencies
of resistance/susceptibility to quinolones as determined by
real-time PCR among diﬀerent hosts showed signiﬁcantly
lower resistance rates in beef cattle than in the other species
(P< . 05).
4. Discussion
The use of diﬀerent antimicrobial susceptibility testing
methods, antimicrobial panels, and breakpoints hampers
comparison of antimicrobial resistance distribution data
between studies. Agar dilution is the method most often rec-
ommended for Campylobacter spp. (CLSI), but it is labour-
intensive and diﬃcult to perform in routine laboratories.
Broth microdilution is a fast and easy-to-perform method
that yields reproducible MIC results for C. jejuni [9, 10],
it is commercially available, and the standardised method
was approved by CLSI in 2006 [11]. Antimicrobials and
dilution ranges used in the study herein included those
deﬁned by the EU as a minimum requirement (tetracycline,
erythromycin, ciproﬂoxacin, gentamicin and streptomycin)
and the additional recommendations (ampicillin, amoxi-
cillin and nalidixic acid) [12], along with others commonly
used in clinical practice or in animal productions as such or
their derivatives (Table 1). Since the purpose of this study
was to monitor for antimicrobial resistance surveillance
and detect the development of microbiological resistance,
MIC epidemiological cut-oﬀ values rather than clinical
breakpoints were used, which in some cases resulted in
a higher proportion of isolates categorized as resistant.
When compared with the 2006 European Community
report on trends and sources of zoonotic agents and
antimicrobial resistance [2] using the same cut-oﬀs, our
results showed a high proportion of poultry strains resistant
to ciproﬂoxacine, above the estimates reported by most
countries. Resistance to tetracycline was within the ranges
estimated for several Member States. These, along with
the absence of erythromycin, streptomycin. and gentamicin
resistance represent a situation similar to that reported by
the Netherlands or Germany, but signiﬁcantly diﬀerent toInternational Journal of Microbiology 5
Table 3: Resistance phenotypes of C. jejuni isolates by source.
No. of resistances Resistance proﬁle(a) Poultry (n = 19) Sheep (n = 25) Beef cattle (n = 14) Dairy cattle (n = 14) Total (n = 72)
n (%) n (%) n (%) n (%) n (%)
7 CpNxTDxAmAxK 0 (0.0) 0 (0.0) 0 (0.0) 1 (7.1) 1 (1.4)
6 CpNxTDxAmAx 4 (21.0) 1 (4.0) 1 (7.1) 3 (21.4) 9 (12.5)
4 CpNxTDx 4 (21.0) 9 (36.0) 1 (7.1) 3 (21) 17 (23.6)
4 CpNxAmAx 2 (10.5) 2 (8.0) 0 (0.0) 0 (0.0) 4 (5.6)
4 TDxAmAx 0 (0.0) 0 (0.0) 0 (0.0) 1 (7.1) 1 (1.4)
3 TAmAx 0 (0.0) 1 (4.0) 0 (0.0) 0 (0.0) 1 (1.4)
2 CpNx 1 (5.3) 2 (8.0) 3 (21.4) 1 (7.1) 7 (9.7)
2 TDx 0 (0.0) 3 (12.0) 2 (14.3) 1 (7.1) 6 (8.3)
2 AmAx 2 (10.5) 1 (4.0) 0 (0.0) 0 (0.0) 3 (4.2)
0 Susceptible 6 (31.6) 6 (24.0) 7 (50.0) 4 (28.6) 23 (31.9)
(a)Ax, Amoxicillin; Am, Ampicillin; Cp, Ciproﬂoxacin; Dx, Doxicycline; K, Kanamycin; Nx, Nalidixic acid; T, Tetracycline
Poultry Beef C Dairy C Sheep
P = .0139
P = .0158 P = .0039
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Figure 1: Box Plots representing log2-transformed MIC values distribution among host species for (a) Quinolones, (b) Tetracyclines, (c)
β-lactams. To standardise MIC values for all antimicrobials, MICs were divided by the lowest value tested for each antimicrobial before log
transformation. The boundary of the box closest to zero indicates the 25th percentile; the continuous line within the box marks the median;
a dashed line marks the mean and the boundary of the box farthest from zero indicates the 75th percentile. Error bars above and below the
box indicate the 90th and 10th percentiles. Outlying points are represented as closed dots. Signiﬁcant diﬀerences (P<. 05) are indicated with
their corresponding P values.6 International Journal of Microbiology
Spain, that reported much higher resistance levels to all these
antimicrobials. Also in broilers, in a survey carried out from
1997 to 1998 in slaughterhouses in a nearby region in Spain
(La Rioja) using agar disk diﬀusion [13], approximately
99% of C. jejuni isolates were ﬂuoroquinolone resistant;
resistance to gentamicin was also higher than in the present
study, but comparable for tetracycline and ampicillin. The
poultrystrainsanalysedinthestudyhereinhadbeenisolated
from free-range chicken farms [7] where antibiotics are
rarely used and entirely conﬁned to therapeutic treatment
of diseased animals, whereas in the abovementioned studies
strains originated from broilers. Although the results of
studies comparing the antimicrobial susceptibility patterns
of Campylobacter recovered from poultry raised in diﬀerent
production systems (conventionally reared versus free-range
chickens) are somewhat inconclusive, it does appear that
ﬂuoroquinolone resistance is more frequently reported in
isolates from conventionally reared poultry [14]. However,
recentstudiessuggestthatﬂuoroquinolone-resistantCampy-
lobacter, once evolved, may continue to persist in chicken
ﬂocks regardless of the use of ﬂuoroquinolones. Luo et al.
[15] examined the eﬀect of a resistance-conferring C257T
mutation in the gyrA gene on the ﬁtness of ﬂuoroquinolone-
resistant C. jejuni in chicken. Their results demonstrated
enhanced in vivo ﬁtness of ﬂuoroquinolone-resistant C.
jejuni in chicken in the absence of antibiotic selection pres-
sure, suggesting that ﬂuoroquinolone-resistant isolates may
be able to persist in the chicken reservoirs even without the
usage of ﬂuoroquinolone antimicrobials. Epidemiological
studies also showed the persistence of ﬂuoroquinolone-
resistant C. jejuni in chicken ﬂocks after ceasing on-farm ﬂu-
oroquinoloneuse[16].Inthisstudy,alltheﬂuoroquinolone-
resistant isolates had the C257T mutation in the gyrAg e n e .
In dairy cattle, resistance was higher to tetracyclines
followed by ﬂuoroquinolones, a similar pattern to that found
by Englen et al. [17] in US dairy cattle despite diﬀerences in
the method and breakpoints used. Contrary to our results,
the same authors [18] had reported similar levels of tetra-
cycline resistance in feedlot cattle. In Europe, resistance is
highly variable from country to country [19, 20], with either
tetracyclines or quinolones as the antimicrobials towards
resistance are higher among C. jejuni isolated from beef
cattle.Macrolideresistance,absentinthisstudy,wasreported
albeit at low levels in USA and Europe [17–19]. Despite
the high prevalence of C. jejuni in sheep, few investigations
on antimicrobial resistance have been conducted in ovine
isolates and comparable data is scarcely available. Zweifel
et al. [21] found very low rates of resistance in Swiss ovine
campylobacters using disk diﬀusion and the NCCLS stan-
dards. In the present study, along with quinolones, resistance
was also high to tetracyclines. Interestingly, a recent study
reported the emergence of a tetracycline-resistant C. jejuni
cloneassociatedwithoutbreaksofovineabortionintheUSA
[22]. In our region, Campylobacter infection is not among
the main causes of ovine abortion [23].
The developed gyrA and 23S rRNA genes SNP detection
assays by real-time PCR were able to detect the correct
genotype in all cases providing a rapid and reproducible
screening method for quinolone and macrolide resistance
detection, which allowed the analysis of a larger set of
strains. Other molecular methods commonly used to detect
the point mutation at the 86-codon of the gyrAg e n ea r e
mismatch ampliﬁcation mutation assay PCR (MAMA-PCR)
[24], single-strand conformation polymorphism analysis
[25], the latter having the advantage of detecting mutations
at neighbouring positions, but both diﬃcult to standardize
or automate. Real-time PCR has also been used, either
using TaqMan probes [26] or by means of melting peak
analysis [27], also used to detect the A2075G mutation
in the 23S rRNA genes associated to macrolide resistance
in Campylobacter spp. [28]. The real-time PCR designs
presentedhereinforgyrAand23SrRNAgenesSNPdetection
takeadvantageofprobemodiﬁcationsthatprovideincreased
thermal stability allowing shorter probes to be used, and
therefore, conferring increased sequence-speciﬁcity com-
pared to ordinary DNA probes, that is, TaqMan probes
conjugated with MGB ligands at the 3  end and probes with
LNA nucleotides at diﬀerent positions. This characteristic
allowed us to design probes that avoid the polymorphic
site described by Wilson el al. [26] in the third position of
theirgyrAprobe,thusobtainingbetterallelicdiscrimination.
Also important are other possible mutations within the
sequences recognised by the probes described for both the
gyrA gene (A256G, associated to nalidixic acid resistance,
but not ciproﬂoxacin resistance) and the 23S rRNA gene
(A2058C, associated to higher erythromycin MICs) of a few
C. jejuni isolates [29, 30]. These mutations would most
likely produce a negative or inconclusive result by real-time
PCR and would require sequencing analysis. Nevertheless,
this was never the case in the study herein, where cross-
resistance between nalidixic acid and ciproﬂoxacin was
found in all isolates, in agreement to other studies in Spain
[13, 31], and erythromycin MICs were low. Here, real-time
PCR detected the correct genotype in all cases providing a
rapid and reproducible screening method for quinolone and
macrolide resistance detection, which allowed the analysis of
a larger set of strains. Thus, whereas the number of isolates
tested phenotypically was too small to provide any statistical
resolution, signiﬁcantly lower quinolone resistance rates in
beef cattle than in the other species could be observed when
analysing results obtained by real-time PCR.
Resistance to ﬂuoroquinolones has increased over the
past years in many parts of the world [1–3]. In Spain,
ﬂuoroquinolone-resistant C. jejuni isolated from humans
were ﬁrst reported in 1988 [32] and resistance prevalence
has increased since then to high levels [13, 31, 33]. The
activity of erythromycin against C. jejuni human isolates,
the antibiotic of choice for the treatment of diarrhea caused
by Campylobacter strains (especially in infants), seems to
remain stable at rates below 5% [13, 31]. This stable
macrolide activity is in agreement with the absence of
resistance among animal isolates observed in this study. This
susceptibility is reassuring but active and more extensive
antimicrobial surveillance in campylobacters from animals
is needed to allow future informed decisions about how
macrolide antibiotics could be used in food animals while
still safeguarding human health. The real-time SNP discrim-
ination protocols presented herein provide the processabilityInternational Journal of Microbiology 7
required for such purposes. The analysis of large number of
isolates, performed in combination with MIC determination
on a smaller selection, should help in early detection of
resistance development.
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